In this video, Kalen J. Petersen, PhD, discusses his team's recent study examining the impact of multiple factors on brain aging among individuals living with HIV when compared with individuals without HIV,...
In this video, Monica Gandhi, MD, MPH, discusses the results of her team's recent study which examined the use of long-acting antiretroviral therapy (LA-ART) in individuals with HIV with viremia, which is...
In this interview, Jessica Rodrigues, MS, answers questions about barriers to the access of pre-exposure prophylaxis (PrEP), funding, stigma, and choices of PrEP. She also spoke about these topics during...
PrEP has become more mainstream in the media, and the USPSTF recently recommended PrEP for all at-risk populations. Richard Chaisson, MD, shines light on these at-risk populations.
In this video, Monica Gandhi, MD, MPH, discusses advances in HIV treatment strategies, including treatment for naive patients, treatment-resistant patients, and patients on long-acting ART. She also...
In this podcast, Niha Idrees, PharmD, and Melissa Badowski, PharmD, MPH, BCIDP, speak about their team's research evaluating the incidence of hypertension, diabetes, and hyperlipidemia in patients on...
In this podcast, Daniel Lee, MD, answers our questions about dealing with weight gain in patients with HIV, a topic he presented at the ACT HIV 2021 Conference.
In this podcast, Jonathan Karn, PhD, talks about his session "Novel Findings of Neuronal Modulation of HIV Expression in Microglia" at the Conference on Retroviruses and Opportunistic Infections...
Joshua Khalili, MD, from UCLA, discusses his new paper published in JAMA Internal Medicine, which details the key role primary care practitioners play in prescribing pre-exposure prophylaxis to uninfected...
New research indicates that many women living with HIV may prefer a monthly long-acting injectable antiretroviral therapy, once FDA-approved, instead of daily pills. Consultant360 discussed these findings...
